Skip to Content

1,894 Results Found

  • Review
  • Open Access
8 Citations
4,090 Views
18 Pages

mRNA Technology and Mucosal Immunization

  • Antonio Toniolo,
  • Giuseppe Maccari and
  • Giovanni Camussi

17 June 2024

Current mRNA vaccines are mainly administered via intramuscular injection, which induces good systemic immunity but limited mucosal immunity. Achieving mucosal immunity through mRNA vaccination could diminish pathogen replication at the entry site an...

  • Review
  • Open Access
24 Citations
4,780 Views
20 Pages

Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization

  • Salvatore Calogero Gaglio,
  • Massimiliano Perduca,
  • Donato Zipeto and
  • Giuseppe Bardi

6 August 2023

The mucosal barrier constitutes a huge surface area, close to 40 m2 in humans, located mostly in the respiratory, gastrointestinal and urogenital tracts and ocular cavities. It plays a crucial role in tissue interactions with the microbiome, dietary...

  • Feature Paper
  • Review
  • Open Access
52 Citations
8,038 Views
20 Pages

14 October 2021

Currently, most vaccines available on the market are for parental use; however, this may not be the best option on several occasions. Mucosal routes of administration such as intranasal, sublingual, and buccal generate great interest due to the benef...

  • Article
  • Open Access
8 Citations
3,054 Views
15 Pages

Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV

  • Dongliang Liu,
  • Sheng Zhang,
  • Ethan Poteet,
  • Christian Marin-Muller,
  • Changyi Chen and
  • Qizhi Yao

23 October 2021

Development of a vaccine that can elicit robust HIV specific antibody responses in the mucosal compartments is desired for effective prevention of HIV via sexual transmission. However, the current mucosal vaccines have either poor immunogenicity when...

  • Article
  • Open Access
1 Citations
1,782 Views
15 Pages

24 July 2024

Mucosal immunity is the main defense line against respiratory disease pathogens. Newcastle disease and avian infectious bronchitis are common respiratory diseases in poultry. However, the mucosal immune response is not sufficiently activated and thus...

  • Article
  • Open Access
13 Citations
3,669 Views
18 Pages

Zika virus (ZIKV) infections in humans are mainly transmitted by the mosquito vectors, but human-to-human sexual transmission is also another important route. Developing a ZIKV mucosal vaccine that can elicit both systemic and mucosal immune response...

  • Article
  • Open Access
12 Citations
3,274 Views
21 Pages

Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs

  • Douglas Borges de Figueiredo,
  • Kan Kaneko,
  • Tasson da Costa Rodrigues,
  • Ronan MacLoughlin,
  • Eliane Namie Miyaji,
  • Imran Saleem and
  • Viviane Maimoni Gonçalves

Pneumococcal disease remains a global burden, with current conjugated vaccines offering protection against the common serotype strains. However, there are over 100 serotype strains, and serotype replacement is now being observed, which reduces the ef...

  • Article
  • Open Access
15 Citations
3,440 Views
16 Pages

Delivering vaccines to the posterior nose has been proposed to induce mucosal immunization. However, conventional nasal devices often fail to deliver sufficient doses to the posterior nose. This study aimed to develop a new delivery protocol that can...

  • Review
  • Open Access
60 Citations
21,179 Views
37 Pages

Vaccine Strategies to Elicit Mucosal Immunity

  • Yufeng Song,
  • Frances Mehl and
  • Steven L. Zeichner

13 February 2024

Vaccines are essential tools to prevent infection and control transmission of infectious diseases that threaten public health. Most infectious agents enter their hosts across mucosal surfaces, which make up key first lines of host defense against pat...

  • Article
  • Open Access
2 Citations
3,096 Views
21 Pages

Generating long-lived mucosal and systemic antibodies through respiratory immunization with protective antigens encapsulated in nanoscale biodegradable particles could potentially decrease or eliminate the incidence of many infectious diseases, but r...

  • Review
  • Open Access
10 Citations
11,810 Views
15 Pages

Mucosal Immunity and Trained Innate Immunity of the Gut

  • Tsvetelina Velikova,
  • Issa El Kaouri,
  • Konstantina Bakopoulou,
  • Milena Gulinac,
  • Kremena Naydenova,
  • Martin Dimitrov,
  • Milena Peruhova and
  • Snezhina Lazova

Mucosal immunity and trained innate immunity of the gut play a pivotal role in maintaining intestinal homeostasis and defending against microbial pathogens. This review provides an overview of the mechanisms underlying mucosal immunity and the concep...

  • Review
  • Open Access
16 Citations
7,812 Views
27 Pages

27 November 2024

The growing role of aquaculture in global food security has underscored the need for advanced immunological insights to protect fish health and boost productivity. As aquaculture’s importance rises, understanding fish immunity is crucial for de...

  • Feature Paper
  • Review
  • Open Access
12 Citations
7,556 Views
22 Pages

26 January 2024

The respiratory tract, the first-line defense, is constantly exposed to inhaled allergens, pollutants, and pathogens such as respiratory viruses. Emerging evidence has demonstrated that the coordination of innate and adaptive immune responses in the...

  • Review
  • Open Access
40 Citations
8,367 Views
26 Pages

The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants

  • Nathaly Vasquez-Martínez,
  • Daniel Guillen,
  • Silvia Andrea Moreno-Mendieta,
  • Sergio Sanchez and
  • Romina Rodríguez-Sanoja

24 March 2023

Mucus is a viscoelastic gel that acts as a protective barrier for epithelial surfaces. The mucosal vehicles and adjuvants need to pass through the mucus layer to make drugs and vaccine delivery by mucosal routes possible. The mucoadhesion of polymer...

  • Review
  • Open Access
14 Citations
4,286 Views
14 Pages

14 November 2023

Oral mucositis (OM) is a significant complication of cancer therapy with limited management strategies. Whilst inflammation is a central feature of destructive and ultimately ulcerative pathology, to date, attempts to mitigate damage via this mechani...

  • Article
  • Open Access
20 Citations
6,702 Views
14 Pages

Mucosal Immune Response to Feline Enteric Coronavirus Infection

  • Morgan Pearson,
  • Alora LaVoy,
  • Samantha Evans,
  • Allison Vilander,
  • Craig Webb,
  • Barbara Graham,
  • Esther Musselman,
  • Jonathan LeCureux,
  • Sue VandeWoude and
  • Gregg A. Dean

27 September 2019

Feline infectious peritonitis is a devastating, fatal disease of domestic cats caused by a pathogenic mutant virus derived from the ubiquitous feline enteric coronavirus (FECV). Infection by FECV is generally subclinical, and little is known about th...

  • Article
  • Open Access
1 Citations
2,068 Views
21 Pages

Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity

  • Raul Ramos Pupo,
  • Laura M. Reyes Diaz,
  • Gisela M. Suarez Formigo,
  • Yusnaby Borrego Gonzalez,
  • Miriam Lastre Gonzalez,
  • Danay Saavedra Hernandez,
  • Tania Crombet Ramos,
  • Belinda Sanchez Ramirez,
  • Roberto Grau and
  • Jeroen F. J. Bogie
  • + 3 authors

21 July 2025

Background/Objectives: The ongoing evolution of SARS-CoV-2 has highlighted the limitations of parenteral vaccines in preventing viral transmission, largely due to their failure to elicit robust mucosal immunity. Methods: Here, we evaluated an intrana...

  • Article
  • Open Access
2 Citations
2,414 Views
17 Pages

Evaluation of Immune Response to Mucosal Immunization with an Oral Probiotic-Based Vaccine in Mice: Potential for Prime-Boost Immunization against SARS-CoV-2

  • Galina Leontieva,
  • Tatiana Gupalova,
  • Yulia Desheva,
  • Tatiana Kramskaya,
  • Elena Bormotova,
  • Irina Koroleva,
  • Olga Kopteva and
  • Alexander Suvorov

22 December 2023

Following the conclusion of the COVID-19 pandemic, the persistent genetic variability in the virus and its ongoing circulation within the global population necessitate the enhancement of existing preventive vaccines and the development of novel ones....

  • Review
  • Open Access
9 Citations
6,515 Views
18 Pages

Lactic Acid Bacteria as Mucosal Immunity Enhancers and Antivirals through Oral Delivery

  • Assad Moon,
  • Yuan Sun,
  • Yanjin Wang,
  • Jingshan Huang,
  • Muhammad Umar Zafar Khan and
  • Hua-Ji Qiu

Mucosal vaccination offer an advantage over systemic inoculation from the immunological viewpoint. The development of an efficient vaccine is now a priority for emerging diseases such as COVID-19, that was declared a pandemic in 2020 and caused milli...

  • Review
  • Open Access
11 Citations
12,728 Views
25 Pages

SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity

  • Joshua Tobias,
  • Peter Steinberger,
  • Joy Wilkinson,
  • Gloria Klais,
  • Michael Kundi and
  • Ursula Wiedermann

18 July 2024

Immunity against respiratory pathogens is often short-term, and, consequently, there is an unmet need for the effective prevention of such infections. One such infectious disease is coronavirus disease 19 (COVID-19), which is caused by the novel Beta...

  • Article
  • Open Access
2 Citations
2,191 Views
16 Pages

Teleost Eye Is the Portal of IHNV Entry and Contributes to a Robust Mucosal Immune Response

  • Xinyou Wang,
  • Guangyi Ding,
  • Peng Yang,
  • Gaofeng Cheng,
  • Weiguang Kong and
  • Zhen Xu

21 December 2023

The ocular mucosa (OM) is an important and unique part of the vertebrate mucosal immune system. The OM plays an important role in maintaining visual function and defending against foreign antigens or microorganisms, while maintaining a balance betwee...

  • Article
  • Open Access
1 Citations
2,215 Views
16 Pages

Oral Administration of Zinc Sulfate with Intramuscular Foot-and-Mouth Disease Vaccine Enhances Mucosal and Systemic Immunity

  • Min Ja Lee,
  • Seokwon Shin,
  • Hyeong Won Kim,
  • Mi-Kyeong Ko,
  • So Hui Park,
  • Su-Mi Kim and
  • Jong-Hyeon Park

9 November 2024

Background/Objectives: Foot-and-mouth disease (FMD) remains a significant global threat to livestock farming. Current commercial FMD vaccines present several challenges, including the risk of infection and adverse injection site reactions due to oil-...

  • Review
  • Open Access
73 Citations
15,100 Views
15 Pages

Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence

  • Daniele Focosi,
  • Fabrizio Maggi and
  • Arturo Casadevall

19 January 2022

Sterilizing immunity after vaccination is desirable to prevent the spread of infection from vaccinees, which can be especially dangerous in hospital settings while managing frail patients. Sterilizing immunity requires neutralizing antibodies at the...

  • Review
  • Open Access
24 Citations
4,458 Views
28 Pages

15 April 2023

The global rollout of COVID-19 vaccines has played a critical role in reducing pandemic spread, disease severity, hospitalizations, and deaths. However, the first-generation vaccines failed to block severe acute respiratory syndrome coronavirus 2 (SA...

  • Review
  • Open Access
75 Citations
13,265 Views
21 Pages

Host health depends on the intestinal homeostasis between the innate/adaptive immune system and the microbiome. Numerous studies suggest that gut microbiota are constantly monitored by the host mucosal immune system, and any slight disturbance in the...

  • Article
  • Open Access
2 Citations
1,190 Views
12 Pages

Diarrhea in piglets causes intestinal inflammation and epithelial damage. Weaned piglets fed with Bacillus subtilis (B.S) have enhanced intestinal mucosal immunity and reduces diarrhea in piglets. However, the immune system of newborn piglets is imma...

  • Article
  • Open Access
32 Citations
4,796 Views
18 Pages

Modulation of Pectin on Mucosal Innate Immune Function in Pigs Mediated by Gut Microbiota

  • Weida Wu,
  • Li Zhang,
  • Bing Xia,
  • Shanlong Tang,
  • Jingjing Xie and
  • Hongfu Zhang

The use of prebiotics to regulate gut microbiota is a promising strategy to improve gut health. Pectin (PEC) is a prebiotic carbohydrate that enhances the health of the gut by promoting the growth of beneficial microbes. These microbes produce metabo...

  • Article
  • Open Access
3 Citations
2,270 Views
15 Pages

17 November 2023

Group A Streptococcus (GAS) is a major human pathogen for which there is no licensed vaccine. To protect against infection, a strong systemic and mucosal immune response is likely to be necessary to prevent initial colonization and any events that mi...

  • Review
  • Open Access
4 Citations
4,344 Views
11 Pages

Neisseria meningitidis causes a devastating invasive disease but is also a normal colonizer of the human nasopharynx. Due to the rapid progression of disease, the best tool to protect individuals against meningococcal infections is immunization. Clin...

  • Communication
  • Open Access
1,697 Views
11 Pages

XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel Disease

  • Simon Woelfel,
  • Joel Dütschler,
  • Daniel Junker,
  • Marius König,
  • Georg Leinenkugel,
  • Claudia Krieger,
  • Samuel Truniger,
  • Annett Franke,
  • Seraina Koller and
  • Stephan Brand
  • + 10 authors

16 July 2025

Background: Mucosal immunity plays a pivotal role in preventing infections with SARS-CoV-2. While COVID-19 mRNA vaccines induce robust systemic immune responses in patients with inflammatory bowel disease (IBD), little is known about their efficacy i...

  • Article
  • Open Access
1 Citations
1,994 Views
18 Pages

RSV Vaccine with Nanoparticle-Based Poly-Sorbitol Transporter (PST) Adjuvant Improves Respiratory Protection Against RSV Through Inducing Both Systemic and Mucosal Humoral Immunity

  • Seong-Mook Jung,
  • Soo Ji Kim,
  • Young Chae Park,
  • Eun Sang Seo,
  • Cheol Gyun Kim,
  • Taewoo Kim,
  • Sumin Lee,
  • Eunjin Cho,
  • Jun Chang and
  • Young Min Son
  • + 3 authors

29 November 2024

Background/Objectives: Respiratory syncytial virus (RSV) causes symptoms similar to a mild cold for adults, but in case of infants, it causes bronchitis and/or pneumonia, and in some cases, mortality. Mucosal immunity within the respiratory tract inc...

  • Article
  • Open Access
1,876 Views
17 Pages

Impact of COVID-19 on Mucosal Immunity and Antibody Responses in COVID Vaccinees

  • Priya Kannian,
  • Muruganantham Lillimary Eniya,
  • Pasuvaraj Mahanathi,
  • Arul Gracemary,
  • Nagalingeswaran Kumarasamy and
  • Stephen J. Challacombe

12 September 2025

Background and Objectives: SARS-CoV-2 infection initiates at mucosal surfaces, and mucosal immunity may influence the nature and severity of infection. Little is known about the induction of mucosal immunity by vaccination in COVID-19 convalescents....

  • Article
  • Open Access
1 Citations
1,797 Views
18 Pages

Effects of High-Mobility Group Box-1 on Mucosal Immunity and Epithelial Differentiation in Colitic Carcinoma

  • Takamitsu Sasaki,
  • Rina Fujiwara-Tani,
  • Yi Luo,
  • Ruiko Ogata,
  • Rika Sasaki,
  • Ayaka Ikemoto,
  • Yukiko Nishiguchi,
  • Chie Nakashima,
  • Shingo Kishi and
  • Hiroki Kuniyasu
  • + 3 authors

Abnormalities in mucosal immunity are involved in the onset and progression of ulcerative colitis (UC), resulting in a high incidence of colorectal cancer (CRC). While high-mobility group box-1 (HMGB1) is overexpressed during colorectal carcinogenesi...

  • Article
  • Open Access
7 Citations
3,351 Views
24 Pages

Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV–ΔG–Spike Vaccine

  • Yfat Yahalom-Ronen,
  • Sharon Melamed,
  • Boaz Politi,
  • Noam Erez,
  • Hadas Tamir,
  • Liat Bar-On,
  • Julia Ryvkin,
  • Dena Leshkowitz,
  • Ofir Israeli and
  • Tomer Israely
  • + 6 authors

The emergence of rapidly spreading variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) poses a major challenge to vaccines’ protective efficacy. Intramuscular (IM) vaccine administration induces short-lived immunity but doe...

  • Review
  • Open Access
13 Citations
5,420 Views
15 Pages

Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis

  • Sophie Gohy,
  • Alexandra Moeremans,
  • Charles Pilette and
  • Amandine Collin

20 December 2021

The respiratory epithelium represents the first chemical, immune, and physical barrier against inhaled noxious materials, particularly pathogens in cystic fibrosis. Local mucus thickening, altered mucociliary clearance, and reduced pH due to CFTR pro...

  • Article
  • Open Access
5 Citations
4,676 Views
19 Pages

Modified PEG-Lipids Enhance the Nasal Mucosal Immune Capacity of Lipid Nanoparticle mRNA Vaccines

  • Meng Li,
  • Jing Yi,
  • Yicheng Lu,
  • Ting Liu,
  • Haonan Xing,
  • Xiwei Wang,
  • Hui Zhang,
  • Nan Liu,
  • Zengming Wang and
  • Aiping Zheng

Background/Objectives: Omicron, the predominant variant of SARS-CoV-2, exhibits strong immune-evasive properties, leading to the reduced efficacy of existing vaccines. Consequently, the development of versatile vaccines is imperative. Intranasal mRNA...

  • Review
  • Open Access
1 Citations
3,175 Views
25 Pages

Mucosal Immunity: Lessons from the Lower Respiratory and Small Intestinal Epithelia

  • Kayle B. Dickson,
  • Andrew W. Stadnyk,
  • Juan Zhou and
  • Christian Lehmann

Mucosal epithelia represent a diverse group of tissues that function as a barrier against the external environment and exert a wide variety of tissue-specific secondary functions. This review focuses on the lower respiratory tract and small intestina...

  • Review
  • Open Access
8 Citations
7,369 Views
12 Pages

Systemic, Mucosal, and Memory Immune Responses following Cholera

  • Edward T. Ryan,
  • Daniel T. Leung,
  • Owen Jensen,
  • Ana A. Weil,
  • Taufiqur Rahman Bhuiyan,
  • Ashraful Islam Khan,
  • Fahima Chowdhury,
  • Regina C. LaRocque,
  • Jason B. Harris and
  • Richelle C. Charles
  • + 2 authors

Vibrio cholerae O1, the major causative agent of cholera, remains a significant public health threat. Although there are available vaccines for cholera, the protection provided by killed whole-cell cholera vaccines in young children is poor. An obsta...

  • Review
  • Open Access
1,029 Views
18 Pages

Desquamative Gingivitis and the Oral Microbiome: Insights into Immune–Microbial Interactions in Mucosal Inflammation

  • Bruno Špiljak,
  • Ana Andabak Rogulj,
  • Božana Lončar Brzak,
  • Vlaho Brailo,
  • Ivana Škrinjar,
  • Petar Ozretić and
  • Danica Vidović Juras

17 November 2025

Desquamative gingivitis (DG) is a clinical presentation characterized by erythema, epithelial desquamation, and mucosal fragility, commonly associated with immune-mediated diseases such as oral lichen planus (OLP), mucous membrane pemphigoid (MMP), a...

  • Article
  • Open Access
27 Citations
4,428 Views
16 Pages

18 October 2019

The intestinal mucosal barrier plays an important role in systemic immune functions. This study aimed to find the mechanism of peptide from Alaska Pollock (APP) on intestinal mucosal immunity in mice induced by cyclophosphamide (Cy). Cy-induced decre...

  • Article
  • Open Access
9 Citations
5,047 Views
15 Pages

Previous study revealed that a specific lignin-carbohydrate preparation, named as lignin-rich enzyme lignin (LREL) derived from plant husk, is a novel toll-like receptor 4 ligand and shows a potent immune-stimulatory activity against dendritic cells...

  • Review
  • Open Access
27 Citations
10,913 Views
35 Pages

Mucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease

  • Kathryn G. Sterling,
  • Griffin Kutler Dodd,
  • Shatha Alhamdi,
  • Peter G. Asimenios,
  • Ruben K. Dagda,
  • Kenny L. De Meirleir,
  • Dorothy Hudig and
  • Vincent C. Lombardi

1 November 2022

Recent advances in next-generation sequencing (NGS) technologies have opened the door to a wellspring of information regarding the composition of the gut microbiota. Leveraging NGS technology, early metagenomic studies revealed that several diseases,...

  • Article
  • Open Access
6 Citations
2,833 Views
18 Pages

Polysaccharide from Atractylodes macrocephala Koidz Binding with Zinc Oxide Nanoparticles as a Novel Mucosal Immune Adjuvant for H9N2 Inactivated Vaccine

  • Xiaopan Liu,
  • Xinyi Lin,
  • Hailong Hong,
  • Jing Wang,
  • Ya Tao,
  • Yuying Huai,
  • Huan Pang,
  • Mingjiang Liu,
  • Jingui Li and
  • Ruonan Bo

9 February 2024

H9N2 avian influenza poses a significant public health risk, necessitating effective vaccines for mass immunization. Oral inactivated vaccines offer advantages like the ease of administration, but their efficacy often requires enhancement through muc...

  • Article
  • Open Access
32 Citations
8,699 Views
17 Pages

Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization

  • Shaswath S. Chandrasekar,
  • Yashdeep Phanse,
  • Rachel E. Hildebrand,
  • Mostafa Hanafy,
  • Chia-Wei Wu,
  • Chungyi H. Hansen,
  • Jorge E. Osorio,
  • M. Suresh and
  • Adel M. Talaat

6 February 2021

The rapid transmission of SARS-CoV-2 in the USA and worldwide necessitates the development of multiple vaccines to combat the COVID-19 global pandemic. Previously, we showed that a particulate adjuvant system, quil-A-loaded chitosan (QAC) nanoparticl...

  • Review
  • Open Access
5 Citations
4,467 Views
10 Pages

17 July 2023

The idea of a common mucosal immune system (CMS) is 50 years old. Its relevance to immune protection at mucosal sites and its potential to modulate the impact of vaccination-induced protection against infection of the airway has been poorly understoo...

  • Article
  • Open Access
439 Views
16 Pages

Comparative Evaluation of Mucosal Adjuvants for Intranasal Immunization with a Recombinant RSV Prefusion F Protein

  • Hongqiao Hu,
  • Lei Cao,
  • Jie Jiang,
  • Yuqing Shi,
  • Liang Du,
  • Mengxuan Chu,
  • Hai Li and
  • Yan Zhang

16 February 2026

Background: Respiratory syncytial virus (RSV) remains a major etiologic agent of acute lower respiratory tract infection (ALRTI). Currently licensed RSV vaccines are administered by intramuscular injection and induce limited immunity at the respirato...

  • Article
  • Open Access
4 Citations
2,995 Views
14 Pages

Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

  • Joao Carlos Batista-Liz,
  • Vanesa Calvo-Río,
  • María Sebastián Mora-Gil,
  • Belén Sevilla-Pérez,
  • Ana Márquez,
  • María Teresa Leonardo,
  • Ana Peñalba,
  • Francisco David Carmona,
  • Javier Narvaez and
  • Raquel López-Mejías
  • + 16 authors

22 August 2023

ITGAM–ITGAX (rs11150612, rs11574637), VAV3 rs17019602, CARD9 rs4077515, DEFA (rs2738048, rs10086568), and HORMAD2 rs2412971 are mucosal immune defence polymorphisms, that have an impact on IgA production, described as risk loci for IgA nephropa...

  • Article
  • Open Access
14 Citations
3,358 Views
21 Pages

The vertebrate mucosal barrier comprises physical and immune elements, as well as bioactive molecules, that protect organisms from pathogens. Vitamin D is a vital nutrient for animals and is involved in immune responses against invading pathogens. Ho...

  • Article
  • Open Access
28 Citations
3,984 Views
19 Pages

17 November 2022

The purpose of the study was to investigate the effects of Eimeria tenella infection on the cecal microbiome, the protein concentration of cecal content, cecal mucosal immunity, and serum endotoxin levels in broilers. Three hundred sixty 14-day-old b...

of 38